CD4+T

Xiangjian Wang1, Tao Fu2, Weilian Sun1

  • 1Department of Oral Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.

概括

卡姆雷利祖马布是一种抗PD-1抗体,可以引起罕见的口服液化物反应 (OLR). 这一案例表明CD4+T细胞,而不是CD8+细胞,可能在camrelizumab诱导的OLR病变发生中发挥作用.